Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. VINGE ADVISES ADVINVEST IN ACQUISITION AND ACQUISITION FINANCING OF A MAJORITY STAKE IN ADVANIA
Mandate

VINGE ADVISES ADVINVEST IN ACQUISITION AND ACQUISITION FINANCING OF A MAJORITY STAKE IN ADVANIA

September 19, 2014

Vinge assists a group of Swedish investors through AdvInvest AB in connection with its acquisition financing and acquisition through AdvInvest of a majority stake in Advania. Advania is a Nordic IT company with approx. 1,100 employees in 17 offices in Iceland, Sweden and Norway. Beringer Finance assisted AdvInvest as corporate finance advisor.

Vinge’s team consisted of among others responsible partner Henrik Wenckert (M&A) and project manager Peter Sundgren (M&A) as well as associates Louise Brorsson Salomon (Banking & Finance), Oscar Rydén (Banking & Finance), Albert Wållgren (Banking & Finance), Filip Brosset (M&A), Johan Wahlbom (EU & Competition), Evelina Tejle (Employment & Benefits), Nicklas Thorgerzon (Technology & Outsourcing), Rebecka Weitzberg (Intellectual Property) and Daniel Unger (Real Estate).

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

 Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

 Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025